S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
SWOG Cancer Research Network
SWOG Cancer Research Network
University of California, San Francisco
University of Washington
University of North Carolina, Chapel Hill
Freenome Holdings Inc.
Providence Health & Services
National Cancer Institute (NCI)
Trinity Health Michigan
Elicio Therapeutics
Institut Bergonié
Academic and Community Cancer Research United
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Asan Medical Center
Stanford University
University of Oxford
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Stanford University
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Asan Medical Center
Canadian Cancer Trials Group
Hutchmed
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NantBioScience, Inc.
SWOG Cancer Research Network
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Karolinska Institutet
University of North Carolina, Chapel Hill
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Trinity Health Michigan
Advaxis, Inc.
GlaxoSmithKline
Dartmouth-Hitchcock Medical Center
SWOG Cancer Research Network
Amgen
Amgen
Amgen
Abramson Cancer Center at Penn Medicine
Ege University
University of Southampton
SCRI Development Innovations, LLC
Wake Forest University Health Sciences
Rutgers, The State University of New Jersey
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Maimonides Medical Center
Roswell Park Cancer Institute